Trials / Active Not Recruiting
Active Not RecruitingNCT04972552
Watermelon/UBIQuinone Study
Watermelon/UBIQuinone Study (WUBI-Q Trial)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.
Detailed description
While many observational studies have examined the effects of consuming watermelon in patients without chronic kidney disease, there have been few studies on the consumption of a diet high in watermelon as a means of improving kidney function or reducing protein in the urine. Coenzyme Q is also recognized as a supplement that has benefits for heart health and has anti-oxidative effects, but whether it could be used to improve kidney function or reduce protein in the urine has not been thoroughly examined, especially in the kidney transplant population. The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | coenzyme Q10 | Participants will take 800-1200 mg of coenzyme Q10 capsule per day |
| OTHER | Watermelon diet | Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week |
| OTHER | Usual Diet | Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet |
| OTHER | Placebo | Participants will be asked to take 800-1200 mg of a placebo capsule per day |
Timeline
- Start date
- 2021-11-15
- Primary completion
- 2025-12-30
- Completion
- 2026-06-30
- First posted
- 2021-07-22
- Last updated
- 2025-07-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04972552. Inclusion in this directory is not an endorsement.